share_log

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga ·  Aug 30, 2023 05:31

Gainers

  • Axcella Health (NASDAQ:AXLA) stock rose 14.4% to $0.52 during Tuesday's after-market session. Axcella Health's trading volume hit 61.8 million shares by close, accounting for 4940.4% of its average volume over the last 100 days. The company's market cap stands at $37.9 million.
  • Carmell Therapeutics (NASDAQ:CTCX) stock moved upwards by 8.69% to $4.0. The market value of their outstanding shares is at $92.3 million.
  • ContraFect (NASDAQ:CFRX) stock moved upwards by 8.08% to $0.79. The market value of their outstanding shares is at $8.4 million.
  • Infinity Pharmaceuticals (NASDAQ:INFI) shares rose 7.81% to $0.09. Infinity Pharmaceuticals's trading volume hit 290.2K shares by close, accounting for 8.9% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
  • Beyond Air (NASDAQ:XAIR) stock rose 7.42% to $3.04. The company's market cap stands at $96.4 million.
  • Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 6.61% to $4.48. The company's market cap stands at $19.1 million.

Losers

  • FibroGen (NASDAQ:FGEN) shares declined by 18.0% to $1.05 during Tuesday's after-market session. Trading volume for this security closed at 690.6K, accounting for 20.8% of its average full-day volume over the last 100 days. The company's market cap stands at $103.1 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 12.8% to $1.5. The market value of their outstanding shares is at $3.0 million.
  • Precipio (NASDAQ:PRPO) stock fell 7.69% to $0.34. The market value of their outstanding shares is at $9.2 million.
  • AEON Biopharma (AMEX:AEON) stock fell 7.47% to $3.72. The company's market cap stands at $138.2 million.
  • Vaccinex (NASDAQ:VCNX) shares decreased by 6.83% to $0.21. The market value of their outstanding shares is at $14.6 million.
  • NanoVibronix (NASDAQ:NAOV) shares declined by 6.81% to $1.37. The market value of their outstanding shares is at $2.2 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment